DEMETRI, GD. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med. 2002, 347, 472-480
HEINRICH, MC. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol. 2003, 21, 4342-4349
SIHTO, H. KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors. J Clin Oncol. 2005, 23, 49-57
TARN, C. Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors : therapeutic implications through protein modeling. Clin Cancer Res. 2005, 11, 3668-3677